Atlas Trials

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Clinical trial NCT03603366 · COMPLETED

Trial details

NCT number
NCT03603366
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Cardiovascular DiseaseColorectal Cancer
Start date
2019-08-14
Primary completion
2019-10-14
Enrollment
1028

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.